ACE2 News and Research

RSS
Study explores broad-spectrum, host-acting antiviral strategy to treat SARS-CoV-2

Study explores broad-spectrum, host-acting antiviral strategy to treat SARS-CoV-2

7 Apr 2022
Insights into the pathogenesis of the previous and circulating SARS-CoV-2 variants in mice

Insights into the pathogenesis of the previous and circulating SARS-CoV-2 variants in mice

7 Apr 2022
COVID boosters protect you better than monoclonal antibodies, or natural infection

COVID boosters protect you better than monoclonal antibodies, or natural infection

6 Apr 2022
Investigating high rate of Omicron sublineage breakthrough infections in triple vaccinated healthcare workers

Investigating high rate of Omicron sublineage breakthrough infections in triple vaccinated healthcare workers

6 Apr 2022
Study evaluates the presence of the SARS-CoV-2 spike protein in urine samples collected during the COVID-19 pandemic

Study evaluates the presence of the SARS-CoV-2 spike protein in urine samples collected during the COVID-19 pandemic

6 Apr 2022
Researchers identify novel SARS-CoV-2 Delta-Omicron recombinant strain in Europe

Researchers identify novel SARS-CoV-2 Delta-Omicron recombinant strain in Europe

6 Apr 2022
Study highlights immune escape mutations in viral N-terminal domain supersite of SARS-CoV-2 spike variants

Study highlights immune escape mutations in viral N-terminal domain supersite of SARS-CoV-2 spike variants

6 Apr 2022
Study shows circular RNA vaccine provides robust protection against SARS-CoV-2 in mice and rhesus macaques

Study shows circular RNA vaccine provides robust protection against SARS-CoV-2 in mice and rhesus macaques

6 Apr 2022
Investigating extensive SARS-CoV-2 neutralizing immunoglobulins from COVID-19 recovered subjects

Investigating extensive SARS-CoV-2 neutralizing immunoglobulins from COVID-19 recovered subjects

5 Apr 2022
Prior COVID vaccination induces a more robust antibody response to Omicron

Prior COVID vaccination induces a more robust antibody response to Omicron

5 Apr 2022
Study suggests severe neuroinvasion by SARS-CoV-2 in individuals with alcohol use disorder

Study suggests severe neuroinvasion by SARS-CoV-2 in individuals with alcohol use disorder

4 Apr 2022
An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

3 Apr 2022
Study finds COVID-19 convalescent children had more robust humoral immune responses to SARS-CoV-2 than convalescent adults

Study finds COVID-19 convalescent children had more robust humoral immune responses to SARS-CoV-2 than convalescent adults

1 Apr 2022
Study explores molecular mechanisms underlying SARS-CoV-2 infection of macrophages and the induction of pro-inflammatory cytokines

Study explores molecular mechanisms underlying SARS-CoV-2 infection of macrophages and the induction of pro-inflammatory cytokines

1 Apr 2022
Study identifies a new class of monoclonal antibodies that neutralize both alpha and beta coronaviruses

Study identifies a new class of monoclonal antibodies that neutralize both alpha and beta coronaviruses

1 Apr 2022
TMPRSS2 inhibitor found to be a novel and effective therapeutic option against pan-variant SARS-CoV-2 infections

TMPRSS2 inhibitor found to be a novel and effective therapeutic option against pan-variant SARS-CoV-2 infections

1 Apr 2022
The mucosal antibody response to SARS-CoV-2

The mucosal antibody response to SARS-CoV-2

31 Mar 2022
The evolution of the SARS-CoV-2 spike protein

The evolution of the SARS-CoV-2 spike protein

31 Mar 2022
MERS-CoV-related viruses invade host cells via bat angiotensin-converting enzyme 2 receptors

MERS-CoV-related viruses invade host cells via bat angiotensin-converting enzyme 2 receptors

31 Mar 2022
Study sheds light on biomechanistic reasons why allergic asthma correlates with milder forms of COVID-19

Study sheds light on biomechanistic reasons why allergic asthma correlates with milder forms of COVID-19

31 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback